Retension Pharmaceuticals, Inc. · NASDAQ:RTSN
Eric Keller reported a 7.07% stake in Retension Pharmaceuticals, Inc. (Schedule 13D)
Event Oct 13, 2026 · Filed Oct 14, 2026
Eric Keller reported a 7.07% stake in Retension Pharmaceuticals, Inc., 598,598 shares, with active intent on Oct 13, 2026. Filed Oct 14, 2026 (Schedule 13D).
- Stake
- 7.07%
- Shares
- 598,598
- Intent
- Active
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Eric Keller | 7.07% | 598,598 |
Source
Related
- Retension Pharmaceuticals, Inc.
- Eric Keller
- Retension Pharmaceuticals, Inc. shareholders
- Schedule 13G · Pvg Asset Management Corp · Oct 16, 2026
- Schedule 13G · B Group, Inc. · Oct 16, 2026
- Schedule 13G · Laurence W. Lytton · Oct 15, 2026
- Form 4 · Berendt Michael J · Oct 13, 2026
- Form 4 · Berger Franklin M · Oct 13, 2026